Related Experiment Video
Updated: May 30, 2026

08:48
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Acute and congenital Chagas disease
Caryn Bern1, Diana L Martin, Robert H Gilman
1Parasitic Diseases Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Advances in Parasitology
|August 9, 2011
Summary
A sensitive screening test for congenital Chagas disease in newborns is crucial. Current methods miss many infections, highlighting the need for improved diagnostic tools for early detection and intervention.
Area of Science:
- Infectious Diseases
- Parasitology
- Public Health
Background:
- Chagas disease, caused by Trypanosoma cruzi, presents an acute phase with mild symptoms in most, but severe outcomes in <1%.
- Congenital Trypanosoma cruzi infection affects 1-10% of infants, often asymptomatic, yet carries a significant lifetime risk of cardiac and gastrointestinal disease.
- Current screening protocols in Latin America, involving prenatal serology and cord blood microscopy, have low completion rates (<20%) and limitations in sensitivity.
Purpose of the Study:
- To highlight the limitations of current congenital Chagas disease screening methods.
- To emphasize the need for a sensitive, specific, and practical newborn screening test for Chagas disease.
- To advocate for the integration of Chagas disease into existing newborn screening programs.
Main Methods:
- Review of current diagnostic techniques for congenital Chagas disease, including microscopy, serology, and polymerase chain reaction (PCR).
- Analysis of the effectiveness and limitations of existing screening algorithms in Latin American control programs.
- Evaluation of the sensitivity and early detection capabilities of PCR compared to conventional methods.
Main Results:
- Polymerase chain reaction (PCR) demonstrates higher sensitivity and earlier detection of congenital infections than traditional methods.
- Existing screening programs show suboptimal adherence, with less than 20% of at-risk infants completing all recommended steps.
- A significant proportion of congenital Chagas disease cases may be missed by current screening strategies, leading to delayed diagnosis and potential long-term complications.
Conclusions:
- A critical need exists for a highly sensitive and specific screening test for newborns to effectively diagnose congenital Chagas disease.
- Improved diagnostic tools are essential for integrating Chagas disease into universal newborn screening initiatives.
- Early detection and intervention through effective newborn screening can mitigate the long-term health consequences of Chagas disease.
Related Concept Videos
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...

